Email: pharmatanzar@gmail.com l Phone: 1 613-867-5605; 1 647-448-2150
This organization symbolizes a commitment to excellence and innovation. Its journey started a couple of decades ago and has become one of the leading conglomerates in Bangladesh, marked by determination and resilience. The flagship pharmaceutical company has held a dominant leadership position in the country’s pharmaceutical industry and continues to evolve into a competitive player in the global market. The organization has pharmaceutical, herbal & nutraceuticals, and veterinary divisions.
As one of the largest pharmaceutical enterprises in Bangladesh, it has consistently maintained one of the top positions among all national and multinational. The company achieved a turnover of over US$600 million, securing a double-digit market share and growth.
The company has several production facilities that include oral solid dosage, cephalosporin, ophthalmic, insulin, metered dose inhalation (MDI), and small and large volume parenteral units. Facilities are confirming the plant’s compliance with the stringent requirements of USFDA, UKMHRA, TGA, and WHO-GMP.
Its current export footprint spans over 100 countries, including the USA and, United Kingdom, reflecting the trust and reliability it has earned on the global stage.
With expansive manufacturing capabilities and a forward-thinking approach, this pharmaceutical organization stands as one of the most dynamic and progressive contributors to the healthcare sector in Bangladesh. Through innovation, quality, and a deep commitment to public health, the company continues to set new benchmarks for excellence in pharmaceutical manufacturing and distribution.
Key Highlights:
This pharmaceutical organization stands as one of the most dynamic and progressive contributors to the global healthcare sector. With expansive, state-of-the-art manufacturing facilities, it upholds the highest standards of quality, innovation, and regulatory compliance. The company operates with a mission to improve health and extend lives by delivering a wide array of pharmaceutical products across multiple therapeutic areas.
Its integrated operations cover everything from product development and production to distribution, ensuring a timely and consistent supply to both domestic and international markets. With a robust commitment to research and development, the company consistently introduces advanced and affordable medications that address the evolving needs of patients and healthcare providers.
Stringent adherence to international standards such as WHO-GMP, US FDA, UK MHRA, and EU EMA requirements ensures that the manufacturing processes and quality systems are globally benchmarked. This pharmaceutical leader also heavily invests in training, innovation, and environmental sustainability, reinforcing its long-term vision for ethical and responsible growth.
Key Highlights